Literature DB >> 18786531

Trypanosoma cruzi: immunoglobulin isotype profiles during the acute phase of canine experimental infection with metacyclic or blood trypomastigotes.

W Coura-Vital1, C M Carneiro, H R Martins, M de Lana, V M Veloso, A Teixeira-Carvalho, M T Bahia, R Corrêa-Oliveira, O A Martins-Filho, W L Tafuri, A B Reis.   

Abstract

A detailed investigation has been carried out about the serological profiles of groups of dogs experimentally infected with metacyclic (MT) or blood (BT) trypomastigotes of Berenice-78 Trypanosoma cruzi strain. Peripheral blood was collected from infected dogs and uninfected controls, weekly during 35 days following the acute phase of infection, and immunoglobulin profiles were determined by ELISA. Dogs infected with BT exhibited unaltered levels of IgG2, increases in IgM, IgE, IgA, IgG and IgG1. In contrast, dogs infected with MT presented unaltered levels of IgE and IgG1 and an increase in IgM, IgA, IgG and IgG2 levels. Compared with the MT group, animals infected with BT showed significant increases in IgM on days 7, 14 and 28, in IgA on days 7, 14 and 21, in IgE on days 7 and 14, in IgG on days 14 and 28, and in IgG1 on days 7, 14 and 21. Parasitemia levels of the infected animals were measured over the same time period. No correlations were found between the immunoglobulin profiles and the parasitemia levels. The results demonstrated that the inoculum source (BT or MT) influence the immunoglobulin isotype profile that may drive distinct outcome of acute canine Chagas disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18786531     DOI: 10.1016/j.exppara.2008.08.001

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  6 in total

Review 1.  Modulation of immune response in experimental Chagas disease.

Authors:  Beatriz Basso
Journal:  World J Exp Med       Date:  2013-02-20

2.  Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.

Authors:  José E Aparicio-Burgos; Laucel Ochoa-García; José Antonio Zepeda-Escobar; Shivali Gupta; Monisha Dhiman; José Simón Martínez; Roberto Montes de Oca-Jiménez; Margarita Val Arreola; Alberto Barbabosa-Pliego; Juan C Vázquez-Chagoyán; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2011-05-17

3.  IgE mediates killing of intracellular Toxoplasma gondii by human macrophages through CD23-dependent, interleukin-10 sensitive pathway.

Authors:  Ioannis Vouldoukis; Dominique Mazier; Daniel Moynet; Denis Thiolat; Denis Malvy; M Djavad Mossalayi
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

4.  Different infective forms trigger distinct immune response in experimental Chagas disease.

Authors:  Paula Melo de Abreu Vieira; Amanda Fortes Francisco; Evandro Marques de Meneses Machado; Nívia Carolina Nogueira; Kátia da Silva Fonseca; Alexandre Barbosa Reis; Andrea Teixeira-Carvalho; Olindo Assis Martins-Filho; Washington Luiz Tafuri; Cláudia Martins Carneiro
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

5.  Specific humoral and cellular immunity induced by Trypanosoma cruzi DNA immunization in a canine model.

Authors:  Minerva Arce-Fonseca; Martha A Ballinas-Verdugo; Emma R Abreu Zenteno; Davinia Suárez-Flores; Silvia C Carrillo-Sánchez; Ricardo Alejandre-Aguilar; José Luis Rosales-Encina; Pedro A Reyes; Olivia Rodríguez-Morales
Journal:  Vet Res       Date:  2013-03-11       Impact factor: 3.683

6.  Echocardiographic Findings in Canine Model of Chagas Disease Immunized with DNA Trypanosoma cruzi Genes.

Authors:  Olivia Rodríguez-Morales; Francisco-Javier Roldán; Jesús Vargas-Barrón; Enrique Parra-Benítez; María de Lourdes Medina-García; Emilia Vergara-Bello; Minerva Arce-Fonseca
Journal:  Animals (Basel)       Date:  2020-04-09       Impact factor: 2.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.